Episurf Medical AB (publ) (STO:EPIS.B)
0.0570
+0.0011 (1.97%)
Jul 24, 2026, 5:24 PM CET
Episurf Medical AB Revenue
Episurf Medical AB had revenue of 8.70M SEK in the quarter ending March 31, 2026, with 248.00% growth. This brings the company's revenue in the last twelve months to 25.10M, up 30.05% year-over-year. In the year 2025, Episurf Medical AB had annual revenue of 22.80M with 10.14% growth.
Revenue (ttm)
25.10M
Revenue Growth
+30.05%
P/S Ratio
9.58
Revenue / Employee
1.24M
Employees
21
Market Cap
250.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.80M | 2.10M | 10.14% |
| Dec 31, 2024 | 20.70M | 600.00K | 2.99% |
| Dec 31, 2023 | 20.10M | 1.90M | 10.44% |
| Dec 31, 2022 | 18.20M | 4.40M | 31.88% |
| Dec 31, 2021 | 13.80M | 6.80M | 97.14% |
| Dec 31, 2020 | 7.00M | 1.60M | 29.63% |
| Dec 31, 2019 | 5.40M | 1.10M | 25.58% |
| Dec 31, 2018 | 4.30M | 1.20M | 38.71% |
| Dec 31, 2017 | 3.10M | 439.46K | 16.52% |
| Dec 31, 2016 | 2.66M | -3.98M | -59.96% |
| Dec 31, 2015 | 6.65M | 4.31M | 184.04% |
| Dec 31, 2014 | 2.34M | 643.54K | 37.95% |
| Dec 31, 2013 | 1.70M | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 2.47M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 461.29M |
| Mentice AB | 310.55M |
| OssDsign AB | 172.55M |
| Integrum AB | 96.14M |
| Promimic AB | 49.86M |
| SciBase Holding AB | 45.88M |
| BrainCool AB | 44.02M |
| Ortoma AB | 42.65M |
Episurf Medical AB News
- 2 months ago - Episurf Medical AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Episurf Medical AB Annual report: Q4 2025 - Filings
- 6 months ago - Episurf Medical AB Quarterly report: Q4 2025 - Filings
- 9 months ago - Episurf Medical AB Quarterly report: Q3 2025 - Filings